The Role of Ganglioside GM1 in Cellular Internalization Mechanisms of Poly(amidoamine) Dendrimers-Reference-Cited by-同舟云学术

The Role of Ganglioside GM1 in Cellular Internalization Mechanisms of Poly(amidoamine) Dendrimers

Published:2009-07-07 Issue:8 Volume:20 Page:1503-1513
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Hong Seungpyo¹,Rattan Rahul¹,Majoros István J.¹,Mullen Douglas G.¹,Peters Jennifer L.¹,Shi Xiangyang¹,Bielinska Anna U.¹,Blanco Luz¹,Orr Bradford G.¹,Baker James R.¹,Holl Mark M. Banaszak¹

Affiliation:

1. Programs in Macromolecular Science and Engineering and Biophysics, Departments of Physics, Chemistry, and Biomedical Engineering, and Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan 48109

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc900029k

Reference57 articles.

1. Non-viral gene transfer: Applications in developmental biology and gene therapy

2. Intracellular targeting of polymer-bound drugs for cancer chemotherapy

3. Dendritic polymer macromolecular carriers for drug delivery

4. Dendrimers and dendritic polymers in drug delivery

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System;Materials;2023-11-21

2. Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer;European Journal of Pharmaceutics and Biopharmaceutics;2023-11

3. Progress in Non‐Viral Delivery of Nucleic Acid;Integration of Biomaterials for Gene Therapy;2023-10-05

4. Biological reaction mediated engineered AuNPs facilitated delivery encore the anticancer, antiglycation, and antidiabetic potential of garcinol;Journal of King Saud University - Science;2023-04

5. Polymer-dendrimer hybrids as carriers of anticancer agents;Current Drug Targets;2021-09-06